info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Polyps Companies

Polyps can occur in various parts of the body, but when discussing them in a medical context, they are often associated with the gastrointestinal tract, particularly the colon and rectum. Companies addressing polyps may be involved in the development of diagnostic tools, medical devices, pharmaceuticals, or treatments related to polyp detection and management.

Polyps Companies


Latest Polyps Companies Update:

Exact Sciences and Invitae partner to offer combined Cologuard and genetic testing for colorectal cancer screening. This collaboration aims to provide a more comprehensive approach to early detection. (Oct 5, 2023)


Boston Scientific receives FDA approval for its ExacTech EchoPulse System, an advanced needle guidance technology for colorectal biopsies. This system aims to improve accuracy and minimize complications associated with traditional biopsies. (Sep 20, 2023)


Growing research on the potential of artificial intelligence (AI) in polyp detection and analysis. Studies show AI algorithms can accurately identify polyps in colonoscopies, potentially improving diagnosis and reducing miss rates. (Jan 17, 2024)


Dupixent (dupilumab) approved for chronic rhinosinusitis with nasal polyps. This injectable medication offers a new treatment option for patients with severe nasal polyps. (Jan 6, 2024)


SonoClear Technologies receives FDA clearance for its Rhinostat device, a minimally invasive treatment for nasal polyps. This device uses radiofrequency energy to shrink polyps without surgery. (Nov 17, 2023) Focus on developing new technologies for non-invasive and more comfortable nasal polyp removal procedures. These include advancements in balloon sinuplasty and endoscopic techniques. (Dec 22, 2023)


List of Polyps Key companies in the market

  • Millennium Surgical Corp.

  • Black Smith Surgical

  • B. Braun Melsungen AG

  • Medtronic

  • Cook Medical

  • Endo Pharmaceuticals Inc.

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd.

  • Novartis AG

  • Mylan Inc.

  • Sun Pharmaceuticals



 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.